Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Michigan
Rutgers, The State University of New Jersey
University Hospital, Toulouse
Johns Hopkins University
University of Colorado, Denver
Duke University
Corcept Therapeutics
University Hospital, Rouen
Virtual Tribunal Monastery
Novartis
RECORDATI GROUP
Colorado State University
University of Illinois at Chicago
St. Jude Children's Research Hospital
University of North Carolina, Chapel Hill
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
West Michigan Cancer Center
Corcept Therapeutics
West Virginia School of Osteopathic Medicine
Corcept Therapeutics
University of Pittsburgh
University of Waterloo
Murdoch Childrens Research Institute
Seoul National University Hospital
Universidad Nacional Andres Bello
The University of Hong Kong
Advice Pharma Group srl
University of Waterloo
Royal Marsden NHS Foundation Trust
Fred Hutchinson Cancer Center
Corcept Therapeutics
Olawuyi Racett Nigeria Ltd
Yale University
University of Southern California
University Hospital, Bordeaux
Zhongnan Hospital
Massachusetts General Hospital
Medstar Health Research Institute
University of Iowa
University of Mississippi Medical Center
Duke University
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Stony Brook University
Hamad Medical Corporation
Université de Sherbrooke
Tulane University
Mayo Clinic
Cambridge University Hospitals NHS Foundation Trust
Corcept Therapeutics